Back to CBIO

CITADEL ADVISORS LLC → CBIO

CITADEL ADVISORS LLC CBIO Position History

Crescent Biopharma, Inc. • Healthcare

Quarters held
2
Latest value
$928K
Q3 2026
Peak value
$4.2M
First seen
Q3 2026

Dollar value over time

Show data table
PeriodPosition value
Q3 2026$4.2M
Q3 2026$928K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$928K63.6K——
Q3 2026$4.2M286.1K——

Other funds holding CBIO

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B